NCT07534488 Sacral Erector Spinae Plane Block in Pilonidal Sinus Surgery
| NCT ID | NCT07534488 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medipol University |
| Condition | Sacral Erector Spinae Plane Block |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-04-20 |
| Primary Completion | 2026-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-04-20 with a primary completion date of 2026-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the efficacy of ultrasound-guided Sacral Erector Spinae Plane (ESP) block for postoperative analgesia management in patients undergoing pilonidal sinus surgery under general anesthesia
Eligibility Criteria
Inclusion Criteria: * Patients scheduled for elective pilonidal sinus surgery. * ASA physical status I and II Exclusion Criteria: * Allergy or sensitivity to local anesthetics or opioid drugs. * Infection at the block site. * Alcohol or drug addiction. * Use of anticoagulant agents. * Patient refusal.
Frequently Asked Questions
Who can join the NCT07534488 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Sacral Erector Spinae Plane Block. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07534488 currently recruiting?
Yes, NCT07534488 is actively recruiting participants. Visit ClinicalTrials.gov or contact Medipol University to inquire about joining.
Where is the NCT07534488 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07534488 clinical trial?
NCT07534488 is sponsored by Medipol University. The trial plans to enroll 60 participants.